RIPK1-IN-32
Product Specifications
Target
Interleukin|||NF-?B|||p38 MAPK|||TNF|||RIP kinase
Related Pathways
NF-?B|||MAPK|||Apoptosis|||Immunology/Inflammation
Bioactivity
RIPK1-IN-32 is an RIPK inhibitor with anti-inflammatory properties. It inhibits nitric oxide (NO) release, with an IC50 of 3.26 ?M. Additionally, RIPK1-IN-32 disrupts the RIPK1/NF-?B/MAPK signaling pathway, preventing nuclear translocation of p65 and c-fos, leading to reduced expression of TNF-? and IL-6 and significantly alleviating acute liver injury related to sepsis. This compound is useful for studies on acute liver injury and sepsis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15321834 1 Vial
Lentiviral human SIRPA shRNA (UAS) - Lentiviral human SIRPA shRNA (UAS, iRFP) (100)
Ask
View Details 
MBS7028749-01 0.02 mg
Recombinant Xenopus laevis E3 ubiquitin-protein ligase rnf152-A (rnf152-a)
Ask
View Details